A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer
Titel:
A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer
Auteur:
Heidenreich, A. Rawal, S.K. Szkarlat, K. Bogdanova, N. Dirix, L. Stenzl, A. Welslau, M. Wang, G. Dawkins, F. de Boer, C.J. Schrijvers, D.